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Abstract
Background: Parkinson’s disease (PD) is one of the most common neurodegenerative disorders,
clinically characterized by impaired motor function. Since the etiology of PD is diverse and
complex, many researchers have created PD-related research resources. However, resources for
brain and PD studies are still lacking. Therefore, we have constructed a database of PD-related gene
and genetic variations using the substantia nigra (SN) in PD and normal tissues. In addition, we
integrated PD-related information from several resources.
Results: We collected the 6,130 SN expressed sequenced tags (ESTs) from brain SN normal
tissues and PD patients SN tissues using full-cDNA library and normalized cDNA library
construction methods from our previous study. The SN ESTs were clustered in 2,951 unigene
clusters and assigned in 2,678 genes. We then found up-regulated 57 genes and down-regulated 48
genes by comparing normal and PD SN ESTs frequencies with over 0.9 cut-off probability of
differential expression based on the Audic and Claverie method. In addition, we integrated disease-
related information from public resources. To examine the characteristics of these PD-related
genes, we analyzed alternative splicing events, single nucleotide polymorphism (SNP) markers
located in the gene regions, repeat elements, gene regulation elements, and pathways and protein-
protein interaction networks.
Conclusion: We constructed the PDbase database to capture the PD-related gene, genetic
variation, and functional elements. This database contains 2,698 PD-related genes through ESTs
discovered from human normal and PD patients SN tissues, and through integrating several public
resources. PDbase provides the mitochondrion proteins, microRNA gene regulation elements,
single nucleotide polymorphisms (SNPs) markers within PD-related gene structures, repeat
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Open Accesselements, and pathways and networks with protein-protein interaction information. The PDbase
information can aid in understanding the causation of PD. It is available at http://bioportal.kobic.re.
kr/PDbase/. Supplementary data is available at http://bioportal.kobic.re.kr/PDbase/suppl.jsp
Background
The age-related neurodegenerative diseases prevalence is
growing continuously due to a permanent increase in the
humanlifespan[1].Itaffectsalmosthalfofallpatientswith
dementia. Parkinson’s disease (PD) is the second most
common age-related neurodegenerative disease, which
results in abnormalities in motor function [2]. Due to the
high-frequency of PD, many researchers have tried to find
thecausationofPD.Thediseaseisclinicallycharacterizedby
impaired motor function, manifested by resting tremors,
rigidity, bradykinesia, and postural instability [3]. PD is
caused by the degeneration of dopaminergic neurons in the
substantia nigra (SN) pars compacta [4].
Although the causation of PD is diverse and complex
combination of the mitochondrial proteins’ dysfunction,
genetic variation effects in cell cycles, and environmental
risk factors, it is now clear that genetic factors contribute to
the pathogenesis of the disease [5-9]. However, the etiology
of sporadic PD, occurring in 95% of the cases [9], is still not
fully understood. To solve this problem, several resources
have been incorporated to help PD studies such as MDPD
[10] and PDGene [11]. MDPD provides a unique function-
ality to compare the differences in the type of mutations
among ethnic groups manually examined by biomedical
researchers [10]. PDGene at the Gene Prospector applica-
tion provides evidence about human genes in relation to
Parkinson’s disease and risk factors from association studies
[11].AlthoughusefulintegratedPD-relatedinformationhas
focused on genetic mutation and PD-association studies,
there remains a limitation in public resource-dependent
information. Therefore, we constructed experimental
resourcestoinvestigateawidespectrumofmolecularevents
prior to integrating the PD-related public resources. Because
public databases for SNPs and diseases are large, compli-
cated, and difficult to use, we have developed the pipeline
system to provide disease-related genes and genetic
variations.
Here, we report the PDbase database to capture character-
istics of the general PD-related genes and abundantly
expressed genes in SN (Figure 1). This database contains
experimentally confirmed SN ESTs annotations and
information about genes associated with PD: in detail,
genetic variation, differential gene expression, gene-regulat-
ing elements, mitochondrial proteins, and pathways
associated with PD-related genes. Users can explore the
PD-related information according to the gene name or by
clicking the gene list.
Methods and results
Substantia Nigra (SN) ESTs collection
We collected the 6,130 substantia nigra (SN) expressed
sequenced tags (ESTs) from full-length cDNA libraries of
brain SN normal tissues and PD patients SN tissues using
oligo-capping methods in a previous study [3]. These SN
ESTs were deposited in No.s DT214917~DT221046 at the
dbEST database, NCBI. The full-length cDNA library was
constructed using an improved capping method with the
pCNS-D2 vector [12]. A normalized cDNA library was also
constructed to obtain genes that are rarely expressed by the
previous method [13]. We checked the repeat elements
using RepeatMasker program http://repeatmasker.org. To
get high-quality SN ESTs, we went through several filtering
steps: 1) removing the short length ESTs, 2) removing
ESTs contaminated by genomic DNAs and E. coli, and 3)
removing ESTs not aligned in any UniGene cluster. We
analyzed the PD candidate genes with this ESTs pool
containing 2,850 SN ESTs from PD patients and 2,883 SN
ESTs from normal tissues. We carried out the annotation of
SN ESTs based on UniGene clusters and then obtained
2,679 genes’ information with 5,733 UniGene clusters.
SN ESTs clustering and expression
The annotation of the SN ESTs was carried out using the
human RefSeq mRNA [14] and the UniGene database
(build #217) for similarity comparisons based on the
UniGene clusters (Shown in supplementary Data
Table1). Our SN ESTs were clustered in 2,951 unigene
clusters and assigned in 2,678 genes. Since we con-
structed the full-length cDNA libraries using the oligo-
capping technique [15], these SN ESTs can be resourced
to examine the multiple transcription start sites compar-
ing mRNA transcription start sites. To investigate amino
acid changes, we compared the SN ESTs sequences to the
RefSeq protein sequences using BLASTX [16].
To study the global expression of genes possibly
associated with Sporadic PD constituting most PD
cases [17], we accounted for the number of SN ESTs
from PD patients and normal tissues assigned in same
gene. The frequency of each gene was analyzed by
dividing the number of ESTs of a gene by the number of
total clones merged into the UniGene database build
#217 in each full-length cDNA library. Genes that were
abundantly expressed were selected and listed among the
ESTs. Significant differences in gene expression among
the datasets were calculated using the Audic and Claverie
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expression between the normal full-length SN library
and the PD full-length SN library at a cut-off probability
of 0.9 (shown in supplementary Data Table2). Finally,
we found 57 up-regulated genes and 48 down-regulated
genes through the comparison of normal and PD SN
ESTs frequencies. MBP of them was reported to be up-
regulated in PD SN [19]. The up-regulated genes were
associated with structural constituents of the myelin
sheath, cytokine activity, transcription regulator activity,
GTPase activity, calcium ion binding, or RNA binding on
molecular function. The down-regulated genes were
associated with oxidoreductase activity, serin-type endo-
peptidase inhibitor activity, phosphatidylethanolamine
binding, mu-type opioid receptor binding, Rho GTPase
activator activity, integrin binding, monooxygenase
activity, or lipid binding.
Genomic mapping of expressed sequence clusters
To create a consensus sequence, we mapped the SN ESTs,
mRNAs, and UniGene EST clusters having at least one
mRNA to exclude the pseudo genes onto human genome
using BLAT and SIM4. We used consensus sequences to
eliminate non-consensus features of each UniGene
cluster, after filtering out EST sequencing errors or
contamination by a minority of similar but paralogous
sequences. Then EST-mRNA alignment was generated
Figure 1
O v e r v i e wo ft h eP D b a s es y s t e m . PDbase contains four components: (a) statistics of the substantia nigra (SN) ESTs
discovered from normal and PD patient tissues, (b) functional annotation of the SN ESTs showing alternative splicing events
and the significant differences in expression between normal and PD SN, (c) integrated information containing genes and
genetic variation related to Parkinson’s disease from HGNC, UniProt, dbSNP, OMIM, HGMD, and GAD, (d) characteristics of
the PD-related genes from microRNA elements, repeat elements, genes distribution on gene ontology, bio-pathways, and
protein-protein interaction network.
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sequence that excludes minority features such as
unaligned ends and inserts due to chimeric sequences
or unspliced introns. The matching genomic region was
aligned with the complete set of ESTs and mRNAs for the
UniGene cluster using BLAT [20] and SIM4 [21]. The
SN EST sequences were aligned in human genomic
sequences with a 75% minimum score and 90%
minimum identity. When coordinates had non-canoni-
c a ls p l i c es i t e s ,w ec o n f i r m e dt h ee x o n - i n t r o nj u n c t i o n
sites with the SIM4 program to perform alignments of
expressed and genomic DNA sequence data efficiently
and accurately, allowing for introns in the genomic
sequence, and a relatively small number of sequencing
errors [21].
Alternative splicing analysis of SN ESTs
Alternative splicing was detected by a computational
procedure using genomic-EST-mRNA multiple sequence
alignments. Alternative splicing types were derived from
these isoforms retaining all possible alternative splicing
information [22]. SN ESTs with poor coverage were
filtered out to remove non-consensus splice sites and
regions with poor coverage. We categorized the alter-
native splicing types such as alternative start, alternative
end, alternative 5’ exon, alternative 3’ exon, exon
skipping, mutually excluded exons, or intron retention.
Alternative starts and ends were identified if the first or
last exon in a gene model was part of an alternative
region. Alternative cassettesw e r el a b e l l e da ss u c hi ft h e
junction skipped one exon.
PDbase contains transcripts representing several alter-
native splicing events (Shown in Supplementary data,
Table 3). SN ESTs were associated with alternative
splicing events in 321 genes. To examine candidate
genes having the PD-specific alternative splicing pat-
terns, we compared the alternative splicing patterns of
normal SN ESTs and PD patients ESTs. We found that
thirty-five PD-specific candidate genes having alternative
splicing events were up-regulated in PD SN tissues: for
example, AQP1, DCXR, DKK3, EEF1A1, GNAS, PGK1,
SUCLG1,a n dTHTPA. The major alternative splicing
events in genes up-regulated in PD SN tissues are
alternative transcription start or end sites. This may be
a reason to construct SN full-length cDNA libraries using
the oligo-capping method to replaces the cap structure
specific to the 5’ end of eukaryotic mRNA with
oligonucleotides [12].
Functional annotation
To provide the global PD-related gene features, we
integrated PD-related gene information, as well as
knowledge-based information. Because public databases
for SNPs and diseases are large, complicated, and
difficult to use, their integration is challenging. We
collected 2,701 genes associated with PD and average
323 genetic variations in genomic region through our
pipeline system for the disease-related gene and genetic
integration [23]. This integrated information is based on
human gene nomenclature (HGNC) [24] and UniProt
[25], genetic variation from dbSNP (version 129) [26],
and disease information from Online Mendelian Inheri-
tance in Man (OMIM) [27], Human Gene Mutation
Database (HGMD) [28], and the Genetic Association
database (GAD) [29]. We examined the PD-related gene
distribution to cover several domains of molecular and
cellular biology based on the Gene Ontology database
[30]. In addition, we surveyed the protein-protein
interaction (PPI) of the PD-related genes from the
Human Protein Reference Database (HPRD) [31]. It
has been reported that the degeneration of dopaminergic
neurons of SNpc is conducted by dysfunction of the
mitochondrial complex through activation of mitochon-
dria-dependent apoptotic molecular pathways [5].
Hence, we investigated mitochondrion proteins asso-
ciated with PD from MitoDat (Mendelian Inheritance
and the Mitochondrion) [32]. We found 31 mitochon-
drial proteins located in inner membrane (68%), outer
membrane (19%), inter membrane space (6%), or
matrix (6%). The numbers in parentheses indicate the
percentages of mitochondrial proteins located in each
organelle among the total number of mitochondrial
proteins. There are, for example, solute carrier family 25
(ANT1, ANT2, ANT3), ATP synthase, H+ transporting,
mitochondrial F1 complex (ATP5A1, ATP5B, ATP5C1,
ATP5F1), and kinesin heavy chain member (HK2).
We also investigated molecular and cellular signalling
pathways associated with PD-related genes from the
BioCarta models http://www.biocarta.com/genes/index.
asp and the KEGG databases [33]. To examine the RNA
elements involved in the regulation of PD-related genes,
we searched microRNA elements related to PD genes
from the mirBASE database as experimental micro-RNA
resources [34] and conserved mammalian microRNA
regulatory target sites for conserved microRNA families
in the 3’UTR regions of RefSeq genes predicted by
TargetScanS at the UCSC table track [35]. In addition, we
utilized multiple transcription start sites, CpG island,
and repeat elements on the UCSC table tracks (down-
load March 2009).
Web interface
The PD database server was developed in JAVA and Java
Server Pages connected to MySQL. The main web
interface allows exploration of integrated PD-related
information through an alphabet ordered genes list and
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Web interface of PDbase. PDbase provides user-friendly web interfaces. When a user selects the 'SPP1' gene from the
category search page, search results (a) containing as follows: (1) “EST statistics” part: number of SN ESTs from normal and PD
patients, number of SN ESTs associated with repeat elements and alternative splicing events, and probability of differential gene
expression with SN ESTs. (2) “Gene Information” part: gene-related information about gene symbol and synonymous,
description, HGNC, OMIM, Ensemble Gene, and HPRD. When click each link, user can get more detailed information. (3)
“Genomic variation” part: detailed information about alternative splicing events, repeat elements, and SNPs in gene region
annotated from SN ESTs. (4) “Gene Regulation” part: micro RNA elements to regulate the query gene (SPP1). (5) “Gene
Ontology” part: gene distribution in three gene ontology categories. GO ids, terms, and evidence are based on the Gene
Ontology database. (6) “Network” part: the query gene-related protein-protein interaction and biological pathways, such as
BioCarta and KEGG. When the user clicks on the PPI viewer in a search result page, interactive java applet viewer (b) shows
the interaction network containing the selected protein and its interacting partners.
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(page number not for citation purposes)through query searching. The user can look at all the PD-
related information at once. When the user clicks on a
letter of the alphabet, the total PD-related gene list
starting with the chosen letter can be seen. The user can
then directly obtain results consisting of SN EST
statistics, targeted gene information (name, synonyms,
and title), genetic variation (SNP, alternative splicing
events, and repeat elements), gene regulation (micro-
RNA elements), gene distribution on the Gene ontology,
and Network information such as pathways and PPI
(Figure 2). When the user submits a gene, the system will
return a list of genes related to the query along with gene
aliases and types. When selecting a specific gene, PDbase
shows the SN EST distribution, gene and genetic variants
through the genome browser [36], and provides infor-
mation on network properties of the PDbase through the
PPI viewer [37]. These genetic variation and gene
regulation elements displayed in the genome browser
or PPI viewer facilitate the recognition of the disease-
causing gene characteristics, especially if the SNP or gene
regulation factors lie in the promoter region or in an
intronic sequence [38].
To show an example of a PD-related gene search, we
present query results for a gene, SPP1,w h i c hi ss e c r e t e d
phosphoprotein 1 (osteopontin, bone sialoprotein I, early
T-lymphocyte activation 1). When a user queries this gene,
SPP1, comprehensive information including frequency
differences between the two full-length libraries from SN
PD and normal tissues is seen. There are 19 SN PD ESTs
and 34 SN normal ESTs in the PDbase database. The SPP1
was down-regulated at a statistically significant level in
more than one sample having a probability of 0.977 < p <
0.98. This gene is known as a high anti-apoptotic gene
from a previous cell death activity study [3]. In addition,
the user can get general gene information and genetic
information containing the SNP marks located in this gene
region, repeat elements, and alternative splicing events
from the PD and normal SN ESTs. Three micro-RNAs can
be associated with regulation of this gene, which has
experimentally confirmed protein-protein interaction with
eighteen other proteins and belongs to the regulators of the
bone mineralization pathway. This SPP1 gene was
represented as a PD target gene through our human SN
ESTs analysis and verified using RT-PCR and neurotoxin, a
1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine (MPTP)-trea-
ted mice model [3]. The query results through the PDbase
database are more helpful to researchers than results
obtained from published previous databases.
Conclusion
We constructed a database of PD-related genes and
genetic variation using SN ESTs, called PDbase. PDbase
contains 2,698 genes and the biological characteristics of
these genes in two ways: 1) through 303 cDNA libraries
from human normal and PD’s SN tissues and 2) by
integrating information on disease-related genes and
genetic variation. Mitochondrial DNA variants in PD
play various roles. Mitochondrial dysfunction has been
reported as the etiology of neurodegenerative diseases
[39]. Thus, PDbase also provides the PD-related
mitochondrion proteins, microRNA, Single Nucleotide
Polymorphisms (SNPs) markers within PD-related
gene structures, repeat elements, and pathways and
networks with protein-protein interaction information.
PDbase integrates not only public resources, but also
un-reported PD target genes discovered from normal
and PD SN ESTs. It can serve as specific biomarkers for
PD or neurodegenerative diseases and novel drug
development. Also, PDbase can provide insight into
the pathogenesis of PD and identify molecular targets
of potential therapeutic significance for the neurode-
generation.
Availability and requirements
PDbase is freely available at http://bioportal.kobic.re.kr/
PDbase/. All generated PD-related gene lists can be
found at http://diseasome.kobic.re.kr/. The dynamic
protein-protein interaction viewer based on Java applet
technology requires Java-enabled web browsers.
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